July 2009

Japan PMDA (Pharmaceuticals and Medical Devices Agency) conducted a 3-day on-site inspection at Savior Lifetec Corporation Chunan Facility, for GMP manufacturing of sterile API Meropenem, and granted satisfactory results. PMDA operates under the Japanese Ministry of Health, Labour, and Welfare.

 

December 2008

Savior Lifetec Corporation had won the Innovative Product Award 2008 with the product Merotic (Meropenem for Injection). The award was granted by the Hsinchu Science Park Administration, R.O.C.

 

November 2008

Savior Lifetec Corporation had won the 15th Small and Medium Enterprises Innovation Award for process development and new crystal form of Meropenem. The award was granted by the Ministry of Economic Affairs, R.O.C.

 

August 2008

Japanese Ministry of Health, Labour, and Welfare issued the accreditation certificate of foreign drug manufacturer for sterile drug to Savior Lifetec's Chunan Facility.

July 2008

FDA issued DMF # 21861 for Meropenem and Sodium carbonate (Sterile Bulk).

 

April 2008

Savior Lifetec's Chunan Facility was issued an API cGMP certificate by Taiwan Health Authority.

 

November 2007

FDA issued DMF # 21061 for Meropenem.

 

October 2007

FDA issued DMF # 21004 for Imipenem and Cilastatin sodium for Injection (Sterile Bulk).

 

May 2007

Savior Lifetec's Tainan Facility was issued an API cGMP certificate by Taiwan Health Authority.

 

April 2007

Savior Lifetec Meropenem sterile plant started to operate.